FCH
AGN

Freestone Capital Holdings’s Allergan plc AGN Stock Holding History

Freestone Capital Holdings’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,891
Closed -$335 – 408
2020
Q1 		$335 Buy
+1,891
New +$356K 0.01% 293
2017
Q2 		– Sell
-1,669
Closed -$399K – 371
2017
Q1 		$399K Buy
+1,669
New +$389K 0.03% 294
2013
Q3 		– Sell
-3,267
Closed -$412K – 414
2013
Q2 		$412K Buy
+3,267
New +$370K 0.08% 219

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Freestone Capital Holdings's AGN Position: Q2 2020 in Review

Freestone Capital Holdings sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,891 shares — an estimated $335 sold.

Freestone Capital Holdings first reported a position in AGN in Q2 2013 and held it in 3 quarters. The position peaked at $412K in Q2 2013. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Freestone Capital Holdings reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Freestone Capital Holdings sold 1,891 Allergan plc shares in Q2 2020, an estimated $335.
  • Freestone Capital Holdings first reported a position in Allergan plc in Q2 2013 and held it in 3 quarters.
  • Freestone Capital Holdings's Allergan plc position peaked at $412K in Q2 2013.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Freestone Capital Holdings's 13F filing for Q2 2020, filed 4 Aug 2020.